Showing posts with label
Diagnostics
.
Show all posts
Showing posts with label
Diagnostics
.
Show all posts
Saturday, September 21, 2024
Adaptive Biotechnologies Corp (NASDAQ: ADPT) is a leading biotechnology company specializing in the development of immune-driven medical solutions.
›
Report on Adaptive Biotechnologies Corp (NASDAQ: ADPT) 1. Executive Summary Adaptives's proprietary immune medicine platform combines ...
Friday, August 9, 2024
The partnership between Microsoft and Adaptive Biotechnologies represents a convergence of biotechnology, Ai, medicine and advanced computing, to unlock the secrets of the immune system.
›
Adaptive Biotechnologies Inc. (ticker: ADPT ) is a biotechnology company that specializes in using the adaptive immune system's capabi...
Tuesday, June 25, 2024
Here are two small cap future tech companies we like in the synthetic biology space going forward!
›
From ChatGPT Twist Biosciences and Ginkgo Bioworks: Business Models and Applications Twist Biosciences Business Model: Twist Biosciences ...
Tuesday, May 28, 2024
Ginkgo Bioworks has been bolstering its position as a first mover in Synthetic Biology!
›
. Here are the companies they’ve acquired and the reasons behind each acquisition: Proof Diagnostics : - Ginkgo Bioworks acquired Proof ...
›
Home
View web version
